## MMC: Marsh & McLennan Companies, Inc - XLF: Financial Services

### Executive Summary

No thesis match: PEG 1.85 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($181.52)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Marsh McLennan (NYSE: MMC) unit Mercer to seed £350M UK private markets LTAF**
- Source: Stock Titan | 20251215T110820 | Bullish | Relevance: 100%
- Mercer, a business of Marsh McLennan, plans to invest an initial £350 million from its UK Workplace Savings solutions into the new Schroders Mercer Private Assets Growth Long-Term Asset Fund (LTAF). This initiative aims to increase members' access to private market investments, focusing on private equity and infrastructure equity, with the goal of allocating at least 10% of default pension fund assets to private markets by 2030. The LTAF is expected to go live in Q1 2026, subject to regulatory approval, and will seek to deliver strong, long-term returns and enhance retirement outcomes for members.

**2. Who Owns Marsh & McLennan? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251213T130836 | Somewhat-Bullish | Relevance: 100%
- This article examines the ownership structure and recent insider trading activity of Marsh & McLennan (NYSE: MMC), a global professional services firm. It highlights that large passive institutions are the primary shareholders, while hedge funds show selective accumulation and insider trades are modest, indicating stable long-term fundamentals despite recent stock volatility. The analysis suggests confidence in the company's earnings durability and pricing power.

**3. Marsh & McLennan Companies (NYSE:MMC) Earns Outperform Rating from Analysts at Mizuho**
- Source: MarketBeat | 20251216T133554 | Somewhat-Bullish | Relevance: 100%
- Mizuho analysts initiated coverage on Marsh & McLennan Companies (NYSE:MMC) with an "Outperform" rating and a $212 price target, indicating a potential 13.17% upside. This comes amidst mixed analyst sentiment, with an average "Hold" rating and a target price of $222.35 from other firms. The company reported strong Q3 earnings, beating EPS estimates and showing significant revenue growth and high return on equity.

**4. Marsh & McLennan Companies, Inc. $MMC Shares Sold by Texas Permanent School Fund Corp**
- Source: MarketBeat | 20251215T131528 | Neutral | Relevance: 100%
- Texas Permanent School Fund Corp reduced its stake in Marsh & McLennan Companies ($MMC) by 17.6% in Q2, selling 11,343 shares. Additionally, CEO John Q. Doyle sold 21,079 shares for approximately $3.84 million, decreasing his holding by 19.38%. Despite these sales, the company reported strong Q3 earnings, beating EPS estimates and growing revenue by 11.5% year-over-year, while also announcing a quarterly dividend.

**5. Marsh Mclennan’s mercer to invest in a bespoke long-term asset fund with an initial commitment of £350 million**
- Source: TradingView — Track All Markets | 20251215T110841 | Bullish | Relevance: 100%
- Marsh & McLennan Companies Inc.'s Mercer will invest £350 million in a new bespoke long-term asset fund dedicated to private markets. This investment highlights a strategic move into long-term private market assets by one of the firm's key divisions. The initial commitment signals a significant allocation towards this asset class.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Citigroup | $201 | $211 | -5% |
| 2025-11-20 | Barclays | $206 | $221 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Citigroup | main | Neutral |
| 2025-11-20 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.28M) |
| Sells | 1 ($3.84M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.1%)
- Blackrock Inc.: 7.9% (-3.7%)
- State Street Corpora: 4.4% (+0.4%)
- Capital Internationa: 3.8% (+1.2%)
- Capital World Invest: 3.6% (+0.5%)

### Key Risks

1. Insider selling cluster: $3.8M in recent transactions.
2. Long-term trend broken: trading 10.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +5.5% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.85 elevated, pricing in significant growth expectations. Forward P/E 18.2x stretched relative to 7% growth. Quality metrics strong (ROE 29%, margin 16%). Balance sheet: $2.3B free cash flow. Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($3.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $92.1B |
| Beta | 0.75 |
| 52W Range | $174.18 - $248.00 |
| Short Interest | 1.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.85 |
| Forward P/E | 18.2 |
| Current P/E | 19.5 |
| YoY Growth | 7.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.6% to 3.9% (+5.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 73rd percentile. MRS_5 at 3.4% confirms short-term momentum alignment. Below SMA200 (0.89x), long-term trend not supportive. MACD histogram positive (0.85), confirming momentum. OFD pattern: +MLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.94% (CS: 74) | Strong |
| RSI_14 | 60.2 | Neutral |
| MACD Histogram | 0.85 | Bullish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.006x | Above |
| vs SMA200 | 0.891x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $187.30
- **Stop Loss:** $181.52 (3.1% risk)
- **Target:** $193.08 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 207
- **Position Value:** $38,771.10
- **Portfolio %:** 38.77%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $1.97)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $1.85 | +4.1% |
| 2025Q2 | $2.66 | $2.72 | +2.1% |
| 2025Q1 | $3.00 | $3.06 | +2.1% |
| 2024Q4 | $1.76 | $1.87 | +6.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*